⏳ Fetching live dividend data...
Home › Calculator › IMRNW Dividend Calculator 2026
Immuron Limited Warrants · NASDAQ
Price: $0.09 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in IMRNW → $28067.28M in 10 years · $52,236,467.26/month
Immuron Limited, an Australian biopharmaceutical firm headquartered in Carlton and founded in 1994, is dedicated to the research, development, and market introduction of polyclonal antibodies. The company maintains a global presence, conducting operations across Australia, Israel, Canada, the United States, and other international territories. Its business activities are segmented into two core areas: Research and Development, and Hyperimmune Products. Immuron currently offers two main products: Travelan: An over-the-counter medication designed to mitigate the risk of travelers’ diarrhea and minor gastrointestinal discomfort. It also functions as a dietary supplement that supports digestive health and protects the gastrointestinal tract. Protectyn: An immune supplement aimed at fostering healthy digestive function and supporting liver vitality. In its development pipeline, Immuron is advancing several candidates: Travelan (IMM-124E): This version is specifically being developed for the U.S. market to reduce the risk of contracting travelers’ diarrhea. IMM-529: A therapeutic treatment for individuals experiencing recurring Clostridium difficile infections. The company has also established strategic collaborations, including a research agreement with the Naval Medical Research Center focused on developing and clinically evaluating a treatment for Campylobacter and enterotoxigenic Escherichia coli infections. Additionally, Immuron holds a collaborative agreement with the Walter Reed Army Institute of Research to create an oral therapeutic specifically for shigellosis.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IMRNW position with:
Real after-tax yield depends on where you live and how you hold IMRNW.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2339.18% | 2336.38% | $233,918 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1988.30% | 1985.50% | $198,830 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1871.34% | 1868.54% | $187,134 / yr |
| 🇬🇧 UK ISA | 0% | 2339.18% | 2336.38% | $233,918 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2134.50% | 2131.70% | $213,450 / yr |
| 🇨🇦 TFSA | 0% | 2339.18% | 2336.38% | $233,918 / yr |
| 🇨🇦 CA Taxable | 25% | 1754.38% | 1751.58% | $175,439 / yr |
| 🇦🇺 Super (pension) | 15% | 1988.30% | 1985.50% | $198,830 / yr |
| 🇦🇺 AU Taxable | 30% | 1637.43% | 1634.63% | $163,743 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1722.22% | 1719.42% | $172,222 / yr |
| 🇫🇷 FR Taxable | 30% | 1637.43% | 1634.63% | $163,743 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
IMRNW pays quarterly — 4 times per year. Next ex-div: TBD.
How IMRNW compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IMRNW sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IMRNW dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Immuron Limited Warrants (IMRNW) is currently trading at $0.09, 95% below its 52-week high. The current dividend yield is 2339.18% based on an annual payout of $2.00 per share.
Immuron Limited Warrants (IMRNW) is a healthcare stock currently trading at $0.09 with a dividend yield of 2339.18%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever